Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
7.3
4.3
Journals
Antibiotics
Special Issues
Antimicrobial Prescribing, Population Use and Resistance, Impact in Global Health,...
share announcement

Antimicrobial Prescribing, Population Use and Resistance, Impact in Global Health, 2nd Edition

A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotics Use and Antimicrobial Stewardship".

Deadline for manuscript submissions: 15 October 2024 | Viewed by 789

Special Issue Editors

Dr. Juan Manuel Vázquez-Lago

E-Mail Website
Guest Editor
Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain
Interests: interventions in public health; active aging; care in chronic diseases; food and nutrition; antibiotics and bacterial resistance; community nursing; health research; epidemiology
Special Issues, Collections and Topics in MDPI journals
Dr. Ana Estany-Gestal

E-Mail Website
Guest Editor
Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain
Interests: clinic epidemiology; public health; methodology; biostatistics; bioethics
Special Issues, Collections and Topics in MDPI journals
Dr. Angel Salgado-Barreira

E-Mail Website
Guest Editor
Departament of Psychiatry, Radiology, Public Health, Nursing and Medicine, University of Santiago de Compostela, 15702 Santiago de Compostela, Spain
Interests: pharmacology; public health; vaccines; methodology; ecological studies
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The first volume of the Special Issue “Antimicrobial Prescribing, Population Use and Resistance, Impact in Global Health” was published last year. It was a great success and published nine papers, thus encouraging us to open a second volume on the same topic.

As a continuation of the Special Issue published in 2022, this second volume will address various public health strategies and interventions, as well as the application of innovations in the management of antibiotics at the hospital level in order to reduce the rate of antimicrobial resistance in the future. This Special Issue welcomes original research papers, reviews, qualitative research, and perspectives.

Potential topics for this Special Issue include, but are not limited to, the following:

  1. Novel methods for the promotion of appropriate antibiotic utilization;
  2. Influence of antimicrobial utilization changes on antimicrobial resistance;
  3. Antimicrobial utilization in special populations (e.g., paediatrics, geriatrics, emergency medicine, chronic diseases at the primary care level…);
  4. Knowledge, attitudes and practice regarding antibiotics utilization and antimicrobial resistance in the public and/or healthcare workers;
  5. New strategies to reduce antimicrobial resistances in hospitalized patients;
  6. New approaches to public health interventions for the improvement of antibiotic utilization;
  7. Risk-stratified approaches to treating common infections in hospitalized patients.

Dr. Juan Manuel Vázquez-Lago
Dr. Ana Estany-Gestal
Dr. Angel Salgado-Barreira
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • epidemiology
  • social behavior
  • antibiotic resistance
  • social factors
  • attitudes
  • knowledge
  • practice
  • qualitative research
  • public health interventions
  • antibiotic prescription
  • community care

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Review

29 pages, 451 KiB  
Review
New Agents Are Coming, and So Is the Resistance
by J. Myles Keck, Alina Viteri, Jacob Schultz, Rebecca Fong, Charles Whitman, Madeline Poush and Marlee Martin
Antibiotics 2024, 13(7), 648; https://doi.org/10.3390/antibiotics13070648 - 13 Jul 2024
Viewed by 606
Abstract
Antimicrobial resistance is a global threat that requires urgent attention to slow the spread of resistant pathogens. The United States Centers for Disease Control and Prevention (CDC) has emphasized clinician-driven antimicrobial stewardship approaches including the reporting and proper documentation of antimicrobial usage and [...] Read more.
Antimicrobial resistance is a global threat that requires urgent attention to slow the spread of resistant pathogens. The United States Centers for Disease Control and Prevention (CDC) has emphasized clinician-driven antimicrobial stewardship approaches including the reporting and proper documentation of antimicrobial usage and resistance. Additional efforts have targeted the development of new antimicrobial agents, but narrow profit margins have hindered manufacturers from investing in novel antimicrobials for clinical use and therefore the production of new antibiotics has decreased. In order to combat this, both antimicrobial drug discovery processes and healthcare reimbursement programs must be improved. Without action, this poses a high probability to culminate in a deadly post-antibiotic era. This review will highlight some of the global health challenges faced both today and in the future. Furthermore, the new Infectious Diseases Society of America (IDSA) guidelines for resistant Gram-negative pathogens will be discussed. This includes new antimicrobial agents which have gained or are likely to gain FDA approval. Emphasis will be placed on which human pathogens each of these agents cover, as well as how these new agents could be utilized in clinical practice. Full article
(This article belongs to the Special Issue Antimicrobial Prescribing, Population Use and Resistance, Impact in Global Health, 2nd Edition)
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop